Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Thakre, Tulsi Rani
- Association of TNF-308 Gene Polymorphism with Cervix Cancer Susceptibility among Women of Chhattisgarh
Abstract Views :176 |
PDF Views:0
Authors
Affiliations
1 School of Studies in Anthropology, Pt. Ravishankar Shukla University, Raipur (C.G.), IN
2 Department of Gynaecology, Dr. B.R. Ambedkar Memorial Hospital, Raipur (C.G.), IN
1 School of Studies in Anthropology, Pt. Ravishankar Shukla University, Raipur (C.G.), IN
2 Department of Gynaecology, Dr. B.R. Ambedkar Memorial Hospital, Raipur (C.G.), IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 5 (2019), Pagination: 2339-2342Abstract
Tumour Necrosis Factor (TNF), being an endogenous pyrogen, is able to induce fever, apoptotic cell death, cachexia, inflammation and to inhibit tumourigenesis. TNF has been shown to mediate carcinogenesis through induction of proliferation, invasion, and metastasis of tumour cells. Polymorphisms within TNF genes can result in pathogenesis and promoting malignant progression of cervix cancer. In the present hospital based case-control study, 230 cervix cancer patients (cases) and 230 controls were studied to determine the association of TNF-308 gene polymorphism with cervical cancer. TNF-308 null genotype showed significance distribution among cases and control (χ2=18.759, df =2, p = 0.00008). Women carrying the heterozygous A allele had a two-fold increased risk of developing cervix cancer (OR=1.775; 95% CI [1.178-2.674]) while the risk of cervix cancer raises to three-fold when A allele is preset in homozygous condition (OR=3.186; 95% CI [1.775-5.719]). These findings indicate that TNF-308 polymorphisms play crucial role in the development of cervix cancer.Keywords
Cervix Cancer (CC), Case-Control Study, TNF-308 Gene Polymorphism, Homozygous and Heterozygous Alleles, Chhattisgarh.
References
- Castellsague XS, de Aguado S, Louie D et al. HPV and cervical cancer in the world: 2007 report. Vaccine. 2007; 25(3):C1-C230.
- Parkin DM. Global cancer statistics in the year 2000. Lancet Oncology. 2001; 2:533-543.
- Parkin DM, Bray FI and Devesa SS. Cancer burden in the year 2000: The global picture. European Journal of Cancer. 2001; 37(8):64-66.
- Bidwell J, Keen L, Gallagher G et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immunology. 1999; 1:3-19.
- Tracey KJ and Cerami A. Tumor necrosis factor, other cytokines and disease. Annual Review of Cell Biology. 1993; 9:317-343.
- Mosaffa F, Kalalinia F, Lage H et al. Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-α alter the expression and function of ABCG2 in cervix and gastric cancer cells. Molecular and Cell Biochemistry. 2012; 363:385393.
- Polunovsky VA, Wendt CH, Ingbar DH et al. Induction of endothelial cell apoptosis by TNF-α: modulation by inhibitors of protein synthesis. Exp Cell Research. 1994; 214:584-594.
- Kroeger KM, Steer JH, Joyce DA et al. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine. 2000; 12:110-119.
- Nedwin GE, Naylor SL, Sakaguchi AY et al. Human lymphotoxin and tumour necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Research. 1985; 13(17):6361-6373.
- Wilson AG, Symons JA, McDowell TL et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of National Academy of Sciences, USA. 1997; 94:3195-3199.
- Kroeger KM, Carville KS and Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Molecular Immunology. 1997; 34:391-399.
- Wu WS and McClain KL. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). Journal of Interferon and Cytokine Research. 1997; 17:631-635.
- Pan F, Tian J, Ji CS et al. Association of TNF-α-308 and -238 polymorphisms with risk of cervical cancer: a meta-analysis. Asian Pacific Journal of Cancer Prevention. 2012; 13:5777-5783.
- Liu L, Yang X, Chen X et al. Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis. Molecular Biology Reports. 2012; 39:2683-2688.
- Li M, Han Y, Wu TT et al. Tumor necrosis factor α -rs1800629 polymorphism and risk of cervical lesions: a meta-analysis. PLoS One. 2013; 8:e69201.
- Zhang HL and Zhang YJ. A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer. Tumour Biology. 2013; 34:1659-1665.
- Coussens IM and Werb Z. Inflammation and cancer. Nature. 2002; 420(6917):860-867.
- Fong CL, Siddiqui AH and Mark DF. Identification and characterization of a novel repressor site in the human tumour necrosis factor alpha gene. Nucleic Acids Research. 1994; 22:1108-1114.
- Duarte I, Santos A, Sousa H et al. G-308 A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer. Biochemistry and Biophysics Research Communication. 2005; 334:588-592.
- Jang WH, Yang YI, Yea SS et al. The 238 tumor necrosis factorα promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Letter. 2001; 166:41-46.
- Sengupta S, Farheen S, Mukherjee N et al. DNA sequence variation and haplotype structure of the ICAM 1 and TNF genes in 12 ethnic groups of India reveal patterns of importance in designing association studies. Annals of Human Genetics. 2004; 68:574-587.
- Gupta V and Sehajpal PK. Rapid detection of single nucleotide (308) polymorphism in TNF-α promoter using ARMS-PCR. Current Science. 85; 2003: 1521-1523.